Pacific Biosciences of California PACB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.87 | 107.20 | -0.13 | -41,197 | -40 | |
| 2025Q3 | 1.28 | 108.36 | -0.13 | -38,877 | -38 | |
| 2025Q2 | 1.24 | 111.69 | -0.14 | -44,853 | -42 | |
| 2025Q1 | 1.18 | 101.01 | -1.44 | -428,934 | -426 | |
| 2024Q4 | 1.83 | -2810.95 | -0.44 | -153,028 | 2 | |
| 2024Q3 | 1.70 | 112.05 | -0.22 | -64,077 | -61 | |
| 2024Q2 | 1.37 | 103.57 | -0.64 | -175,846 | -173 | |
| 2024Q1 | 3.75 | 109.06 | -0.29 | -81,362 | -78 | |
| 2023Q4 | 9.81 | 110.59 | -0.31 | -87,548 | -82 | |
| 2023Q3 | 8.35 | 111.50 | -0.26 | -82,492 | -67 | |
| 2023Q2 | 13.30 | 110.40 | -0.28 | -73,175 | -70 | |
| 2023Q1 | 11.58 | 108.14 | -0.36 | -91,252 | -88 | |
| 2022Q4 | 8.18 | 107.86 | -0.37 | -87,084 | -84 | |
| 2022Q3 | 5.81 | 101.79 | -0.35 | -74,620 | -77 | |
| 2022Q2 | 4.42 | 100.38 | -0.31 | -67,969 | -71 | |
| 2022Q1 | 9.10 | 99.64 | -0.37 | -77,523 | -81 | |
| 2021Q4 | 20.46 | 100.00 | -0.33 | -64,676 | -69 | |
| 2021Q3 | 25.55 | 99.82 | 0.09 | -74,476 | 17 | |
| 2021Q2 | 34.97 | 100.43 | -0.20 | -37,573 | -41 | |
| 2021Q1 | 33.31 | 39.36 | -0.45 | -33,710 | -87 |